Coldstream Capital Management Inc Repligen Corp Transaction History
Coldstream Capital Management Inc
- $4.58 Billion
- Q3 2024
A detailed history of Coldstream Capital Management Inc transactions in Repligen Corp stock. As of the latest transaction made, Coldstream Capital Management Inc holds 2,194 shares of RGEN stock, worth $339,762. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,194
Previous 1,963
11.77%
Holding current value
$339,762
Previous $247,000
31.98%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding RGEN
# of Institutions
488Shares Held
54.2MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.17 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$990 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$781 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$251 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$220 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.59B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....